Pillstats
Rx only · Injection, Solution · Intravenous

Oxaliplatin

Oxaliplatin

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US32 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01XA03
RxCUI (US)32592
US makers13 labelers
Packages41
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7.2K14K22K29K2025 Q12025 Q22025 Q32025 Q42026 Q1
20K
Rx · 2026 Q1
474K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Meitheal Pharmaceuticals Inc.unknown8SUPPLYING
Apotex Corp.unknown5SUPPLYING
NorthStar Rx LLCunknown4SUPPLYING
Sandoz Incunknown4SUPPLYING
Qilu Pharmaceutical Co. Ltd.unknown3SUPPLYING
Gland Pharma Limitedunknown3SUPPLYING
BluePoint Laboratoriesunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Fosun Pharma USA Incunknown2SUPPLYING
Baxter Healthcare Corporationunknown2SUPPLYING
Mylan Institutional LLCunknown2SUPPLYING
Shandong New Time Pharmaceutical Co., Ltd.unknown2SUPPLYING
Eugia US LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 29, 2026
    RESOLVEDShortage resolved: Oxaliplatin Injection (Jiangsu Hengrui Pharmaceuticals Co., Ltd.)

    Oxaliplatin Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Therapeutic category: Oncology.

  • Jun 29, 2026
    SHORTAGEDrug shortage: Oxaliplatin Injection (Jiangsu Hengrui Pharmaceuticals Co., Ltd.)

    Oxaliplatin Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Therapeutic category: Oncology.

  • Oct 20, 2025
    RESOLVEDShortage resolved: Oxaliplatin Injection (Sandoz Inc.)

    Oxaliplatin Injection — reported in shortage by Sandoz Inc.. Therapeutic category: Oncology.

  • Oct 20, 2025
    SHORTAGEDrug shortage: Oxaliplatin Injection (Sandoz Inc.)

    Oxaliplatin Injection — reported in shortage by Sandoz Inc.. Therapeutic category: Oncology.